Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person NTHL1 Q90TER (NTHL1 Q90*) truncation mutant (Weren et al. 20...
| Class:Id | Summation:9630247 |
|---|---|
| _displayName | NTHL1 Q90TER (NTHL1 Q90*) truncation mutant (Weren et al. 20... |
| _timestamp | 2018-11-30 18:58:36 |
| created | [InstanceEdit:9630245] Orlic-Milacic, Marija, 2018-11-30 |
| literatureReference | [LiteratureReference:9630239] Probing the activity of NTHL1 orthologs by targeting conserved amino acid residues [LiteratureReference:9629985] A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer [LiteratureReference:9630214] Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review |
| modified | [InstanceEdit:9630250] Orlic-Milacic, Marija, 2018-11-30 |
| text | NTHL1 Q90TER (NTHL1 Q90*) truncation mutant (Weren et al. 2015) lacks the DNA binding domain and the glycosylase domain and is thus predicted to be unable to recognize and bind damaged DNA, including damaged DNA containing dihydrouracil (DHU), although this has not been experimentally tested. NTHL1 Q287TER (NTHL1 Q287*) truncation mutant (Broderick et al. 2017) lacks a portion of the DNA binding domain, including glutamine residue Q287, important for substrate recognition (Robey-Bond et al. 2017) and is predicted to be unable to recognize and bind damaged DNA, including damaged DNA containing dihydrouracil (DHU), although this has not been experimentally tested. |
| (summation) | [FailedReaction:9630045] Defective NTHL1 truncation mutants do not bind dihydrouracil (DHU) [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by NTHL1 Q90TER (NTHL1 Q90*) truncation mutant (Weren et al. 20... (9630247)
